Recursion Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 S Rio Grande Street, Salt Lake City, Utah

Insiders trading volume in the past year

Recursion Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lux Ventures IV, L.P. Former 10% Owner $138 M Dec 7, 2021
Investment Co PJSC Mubadala 10%+ Owner $137 M Mar 2, 2023
Blake Borgeson Director $52.4 M -$3.48 M -6.22% Jul 9, 2024
Zachary Bogue Director, 10%+ Owner $39.5 M Jul 3, 2023
Christopher Gibson Chief Executive Officer, Director $27.3 M -$8.47 M -23.7% Jun 5, 2024
Dean Y. Li Director $23 M -$396 K -1.69% Jul 1, 2024
MIC Capital Partners (Public) Parallel Cayman, LP 10%+ Owner $14.7 M Nov 1, 2021
Michael Secora Chief Financial Officer $9.53 M -$5.1 M -34.9% Jul 9, 2024
Tina Marriott President and COO $3.86 M -$660 K -14.6% Jun 27, 2024
David J. Mauro Chief Medical Officer $2.44 M May 15, 2024
Shafique Virani Chief Business Officer $1.45 M -$2.26 M -61% Jan 16, 2024
Ramona Doyle Chief Medical Officer $1.28 M May 16, 2022
Zavain Dar Director $750 K -$181 K -19.5% Jul 1, 2024
Chavez R. Martin Director $530 K Apr 1, 2024
Terry-Ann Burrell Director $514 K -$1.41 M -73.3% Jul 1, 2024
Robert Hershberg Director $454 K Jun 3, 2024
Mic Capital Partners (Public) (Us) Im, Llc Other* Nov 1, 2021
Najat Khan Director Apr 16, 2024

Recent Insider Transactions by Companies or Individuals for Recursion Pharmaceuticals, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership